Biohit Oyj Managers' Transactions

23 February 2021 at 10.00 am local time (EET)

Biohit Oyj: Managers' Transactions
Person subject to the notification requirement
Name:                                    Semi Korpela
Position:                                Chief Executive Officer

Issuer:                                   Biohit Oyj
LEI:                                        74370089ATTSNBXJVT29
__________________________________________________


Notification type:                 INITIAL NOTIFICATION
Reference number:              74370089ATTSNBXJVT29_20210222152942_7

Transaction date:                 2021-02-19
Venue:                                   NASDAQ HELSINKI LTD (XHEL)

Nature of the transaction:    DISPOSAL
Instrument type:                    SHARE

 

ISIN:                                        FI0009005482

Transaction details
Volume:
6,217 
Unit price: 2.
1559 EUR

Aggregated transactions
Volume:
6,217 
Volume weighted average price: 2.
1559 EUR

Biohit Oyj

Semi Korpela
CEO


For additional information: 
CEO Semi Korpela,
Biohit Oyj
p. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

About Us

Biohit in briefBiohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Subscribe